ALK Presents Preference Data Comparing EURneffy and Adrenaline Auto-Injectors

At BSACI 2026, ALK presented data comparing preference and ease of use for EURneffy nasal adrenaline spray and adrenaline auto-injector trainer devices. The available report says studies found fear, stress and device bulk can be barriers to carrying or using emergency anaphylaxis treatment.